InvestorsHub Logo
Followers 78
Posts 3635
Boards Moderated 0
Alias Born 01/17/2003

Re: eagle8 post# 559607

Sunday, 01/15/2023 4:53:21 AM

Sunday, January 15, 2023 4:53:21 AM

Post# of 700004
Eagle, I agree 100%. With MHRA approval on the horizon, it's impossible to believe that pps %-wise appreciation will not beat the pants off the dilution rate from here. Yes, more cash will be burned before approval is granted, perhaps even $70-100M, but I can't see MHRA demanding another ph 3 trial before granting marketing approval. With approval, even in the UK, I believe a fair price has to be $2/shr or more, just for starters. Hence short of requiring another full ph 3 trial, the math is totally on the side of being long, IMO. It's really a no-brainer.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News